Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
C.M.J. Steendam, R. Peric, N.C. van Walree, M. Youssef, F.M.N.H. Schramel, P. Brocken, J.W.G. van Putten, V. van der Noort, G.D.M. Veerman, S.L.W. Koolen, H.J.M. Groen, A.M.C. Dingemans, R.H.J. Mathijssen, E.F. Smit, J.G.J.V. Aerts*, NVALT Study Group
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma'. Together they form a unique fingerprint.